Search Results - "Panzara, MA"

Repeated assessment of neuropsychological deficits in multiple sclerosis using the Symbol Digit Modalities Test and the MS Neuropsychological Screening Questionnaire by Benedict, RHB, Duquin, JA, Jurgensen, S, Rudick, RA, Feitcher, J, Munschauer, FE, Panzara, MA, Weinstock-Guttman, B

“…Background Brief cognitive performance tests and self-report measures of neuropsychological symptoms have been proposed for screening purposes in multiple…”
Get full text

A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis by Polman, Chris H, O'Connor, Paul W, Havrdova, Eva, Hutchinson, Michael, Kappos, Ludwig, Miller, David H, Phillips, J. Theodore, Lublin, Fred D, Giovannoni, Gavin, Wajgt, Andrzej, Toal, Martin, Lynn, Frances, Panzara, Michael A, Sandrock, Alfred W

“…This placebo-controlled, randomized trial of patients with relapsing multiple sclerosis demonstrated benefits of natalizumab (an α 4 integrin antagonist) in…”
Get full text

Natalizumab plus Interferon Beta-1a for Relapsing Multiple Sclerosis by Rudick, Richard A, Stuart, William H, Calabresi, Peter A, Confavreux, Christian, Galetta, Steven L, Radue, Ernst-Wilhelm, Lublin, Fred D, Weinstock-Guttman, Bianca, Wynn, Daniel R, Lynn, Frances, Panzara, Michael A, Sandrock, Alfred W

“…In this randomized trial involving patients with relapsing multiple sclerosis who had had relapses despite treatment with interferon, natalizumab in…”
Get full text

Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function by KHARRI, B. O, MAN, S, DUDA, P. W, PANZARA, M. A, RANSOHOFF, R. M, FOX, R. J, GIOVANNONI, G, KOO, A. P, LEE, J.-C, TUCKY, B, LYNN, F, JURGENSEN, S, WOODWORTH, J, GOELZ, S

“…Accelerating the clearance of therapeutic monoclonal antibodies (mAbs) from the body may be useful to address uncommon but serious complications from…”
Get full text

The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL by Hutchinson, M., Kappos, L., Calabresi, P. A., Confavreux, C., Giovannoni, G., Galetta, S. L., Havrdova, E., Lublin, F. D., Miller, D. H., O’Connor, P. W., Phillips, J. T., Polman, C. H., Radue, E.-W., Rudick, R. A., Stuart, W. H., Wajgt, A., Weinstock-Guttman, B., Wynn, D. R., Lynn, F., Panzara, M. A.

“…The AFFIRM and SENTINEL studies showed that natalizumab was effective both as monotherapy and in combination with interferon beta (IFNβ)-1a in patients with…”
Get full text

Natalizumab and Progressive Multifocal Leukoencephalopathy by Adelman, Burt, Sandrock, Alfred, Panzara, Michael A

“…The Brief Reports on natalizumab were referred to Biogen Idec, the manufacturer, which offers the following response: After learning of one confirmed and one…”
Get full text

Natalizumab and central nervous system lymphoma: No clear association by Bozic, Carmen, LaGuette, Julia, Panzara, Michael A., Sandrock, Alfred W.

Get full text

Assessing disability progression with the Multiple Sclerosis Functional Composite by Rudick, RA, Polman, CH, Cohen, JA, Walton, MK, Miller, AE, Confavreux, C, Lublin, FD, Hutchinson, M, O’Connor, PW, Schwid, SR, Balcer, LJ, Lynn, F, Panzara, MA, Sandrock, AW

“…Background The initial Multiple Sclerosis Functional Composite (MSFC) proposal was a three-part composite of quantitative measures of ambulation, upper…”
Get full text

Results of a phase 2, randomized, double-blind, placebo-controlled study by Goodman, AD, Rossman, H, Bar-Or, A, Miller, A, Miller, D H, Schmierer, K, Lublin, F, Khan, O, Bormann, N M, Yang, M, Panzara, MA, Sandrock, A W

“…Objective: To evaluate the safety and tolerability of natalizumab when added to glatiramer acetate (GA) in patients with relapsing multiple sclerosis. The…”
Get full text

Selection for T-cell receptor Vβ-Dβ-Jβ gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis by Oksenberg, Jorge R, Panzara, Michael A, Begovich, Ann B, Mitchell, Dennis, Erlich, Henry A, Murray, Ronald S, Shimonkevitz, Richard, Sherritt, Martina, Rothbard, Jonathan, Bernard, Claude C. A, Steinman, Lawrence

“…Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system in which a restricted cellular immune response has been…”
Get full text

Specific T cell receptor gene rearrangements at the site of muscle degeneration in Duchenne muscular dystrophy by Gussoni, E, Pavlath, GK, Miller, RG, Panzara, MA, Powell, M, Blau, HM, Steinman, L

“…Mononuclear cells infiltrate degenerating muscles of Duchenne muscular dystrophy (DMD) patients. Using a quantitative PCR, we first characterized the T cells…”
Get full text

Diffusion-Weighted Magnetic Resonance Imaging Abnormalities in Bartonella Encephalopathy by Singhal, Aneesh B., Newstein, Michael C., Budzik, Ronald, Cha, Jang-Ho, Rordorf, Guy, Buonanno, Ferdinando S., Panzara, Michael A.

Get full text

T Cell Receptor BV Gene Rearrangements in the Spinal Cords and Cerebrospinal Fluid of Patients with Amyotrophic Lateral Sclerosis by Panzara, Michael A., Gussoni, Emanuela, Begovich, Ann B., Murray, Ronald S., Zang, Ying Q., Appel, Stanley H., Steinman, Lawrence, Zhang, Jingwu

“…Amyotrophic lateral sclerosis (ALS) is a fatal disorder whose etiology and pathogenesis remain unknown. Recent studies, however, have demonstrated the presence…”
Get full text

Analysis of the T cell repertoire using the PCR and specific oligonucleotide primers by Panzara, M A, Gussoni, E, Steinman, L, Oksenberg, J R

“…Applications of PCR have revolutionized the field of immunogenetics particularly in studies of human leukocyte antigen class II polymorphism and more recently…”
Get more information

The polymerase chain reaction for detection of T-cell antigen receptor expression by Panzara, M A, Oksenberg, J R, Steinman, L

“…Applications of the polymerase chain reaction have revolutionized the field of immunogenetics, particularly in studies of human leukocyte antigen class II…”
Get more information

Multiple sclerosis: from immunogenetics to immunotherapy by Oksenberg, J R, Panzara, M A, Steinman, L

Get more information